Health X Platform enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


907	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
30.2	30.2	12.4	33.6	31.7
124	124	195	—	—
22.1	22.1	0.0	0.0	0.0
1,023	—	—	—	—
−8.1	−8.1	−12.4	−33.6	−31.7
₹321.56	—	—	—	—

787	787	865	1,000	994
2.8%	2.8%	0.0%	0.0%	0.0%
0.02×	—	—	—	—

0.70×	—	—	—	—
−15.37×	—	—	—	—
−13.85×	—	—	—	—
1,468	1,319	1,111	1,376	1,040
−66.5	−52.1	−56.0	5.4	−44.0
−73.9	−58.7	−61.9	−3.7	−52.2
—	−73.8	−17.3	38.2	−104
−88.8	−88.8	−27.7	23.9	−132
—	−89.0	−27.7	23.9	−133
—	14.9	10.4	14.2	27.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HEALTHX₹285.00

Health X Platform Limited

· Pharma & Health

₹ CrorePeersSURAKSHA KRSNAA NEPHROPLUS 3BBLACKBIOMcap ₹907 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	906.6
- Cash, Equiv & ST Investments	31.7	33.6	12.4	30.2	30.2
+ Minority Interest	—	—	194.7	124.4	124.4
+ Total Debt	0.0	0.0	0.0	22.1	22.1
Enterprise Value	—	—	—	—	1,022.9
Net Debt (memo)	-31.7	-33.6	-12.4	-8.1	-8.1
EV per Share	—	—	—	—	321.56

Total Capital	993.6	999.5	864.5	787.4	787.4
Total Debt/Total Capital	0.00	0.00	0.00	2.81	2.81
Total Debt/EV	—	—	—	—	0.02

EV/Sales	—	—	—	—	0.70
EV/EBITDA	—	—	—	—	-15.37
EV/EBIT	—	—	—	—	-13.85
Reference Items — Trailing FY Values
Sales	1,039.8	1,375.7	1,111.0	1,319.3	1,467.7
EBITDA	-44.0	5.4	-56.0	-52.1	-66.5
EBIT	-52.2	-3.7	-61.9	-58.7	-73.9
Operating Cash Flow	-104.5	38.2	-17.3	-73.8	—
Free Cash Flow	-132.4	23.9	-27.7	-88.8	-88.8
FCFF (free cash flow to the firm)	-132.9	23.9	-27.7	-89.0	—
Capital Expenditure	27.9	14.2	10.4	14.9	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.